Suchergebnisse - "Claxton, David"

PubPharm (7)

1

A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML

enthalten in: Leukemia | 2024

von Garcia-Manero, G. | Podoltsev, N. | Othus, M. | +23

2

Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)

enthalten in: Cancer | 2021

von Kantarjian, H. | Begna, K. | Altman, J. | +25

3

Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von List, A. | Sun, Z. | Verma, A. | +14

4

Effects of running retraining on biomechanical factors associated with lower limb injury

enthalten in: Human movement science | 2018

von Dunn, M. | Claxton, D. | Fletcher, G. | +2

5

A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemia

enthalten in: PloS one | 2014

von Schimmer, A. | Raza, A. | Carter, T. | +6

6

Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients : a randomised phase 2 study

enthalten in: The Lancet. Oncology | 2012

von Kantarjian, H. | Faderl, S. | Garcia-Manero, G. | +15

CommentIn: Lancet Oncol. 2012 Nov;13(11):1065-6. - PMID 23116996

7

The effect of physical activity homework on physical activity among college students

enthalten in: Journal of physical activity & health | 2009

von Claxton, D. | Wells, G.

1
[1]